Coley Pharmaceutical Group's P2P Acquisition

Coley Pharmaceutical Group raised a round of funding on December 05, 2007. Investors include Pfizer.

Coley Pharmaceutical Group was engaged in the research and development of Toll-like receptor drugs to modulate the immune system for treating cancer, infectious diseases and asthma/allergy.…

Articles about Coley Pharmaceutical Group's P2P Acquisition: